|
Volumn 171, Issue 2, 2014, Pages 131-133
|
Lurasidone and bipolar disorder
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIDEPRESSANT AGENT;
ARIPIPRAZOLE;
CHLORPROMAZINE;
IMIPRAMINE;
LITHIUM;
LURASIDONE;
OLANZAPINE;
QUETIAPINE;
VALPROIC ACID;
ZIPRASIDONE;
ADVERSE OUTCOME;
BIPOLAR DEPRESSION;
BIPOLAR DISORDER;
BIPOLAR MANIA;
DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS;
DIFFERENTIAL DIAGNOSIS;
DRUG APPROVAL;
DRUG EFFICACY;
DSM-5;
DSM-6;
EDITORIAL;
HUMAN;
HYPERMETABOLISM;
IMPAIRED GLUCOSE TOLERANCE;
MANIA;
PRIORITY JOURNAL;
PUBLICATION;
SCHIZOPHRENIA;
WEIGHT GAIN;
BIPOLAR DISORDER;
FEMALE;
HUMANS;
ISOINDOLES;
LITHIUM COMPOUNDS;
MALE;
THIAZOLES;
VALPROIC ACID;
|
EID: 84893689357
PISSN: 0002953X
EISSN: 15357228
Source Type: Journal
DOI: 10.1176/appi.ajp.2013.13091240 Document Type: Editorial |
Times cited : (15)
|
References (9)
|